Ajay Madan

Chief Development Officer, Crinetics Pharmaceuticals.

Companies

Crinetics PharmaceuticalsChief Development Officer Mar 27, 2020 to Mar 2, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Crinetics Pharmaceuticals176,995 shares²Mar 1, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 1, 2022Sold 9,000 shares at $19.88 of Crinetics Pharmaceuticals²
Feb 28, 2022Granted 13,950 shares of Crinetics Pharmaceuticals²
Feb 7, 2022Sold 13,411 shares at $17.83 of Crinetics Pharmaceuticals³
Nov 19, 2021Other 785 shares at $11.02 of Crinetics Pharmaceuticals⁴
Oct 28, 2021Exercised options 106,383 shares at $0.73 of Crinetics Pharmaceuticals⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCrinetics Pharmaceuticals, Chief Development Officer
2
SEC EDGARCrinetics Pharmaceuticals shares after the filing of Mar 1, 2022
3
SEC EDGARForm 4 filed Feb 9, 2022
4
SEC EDGARForm 5 filed Feb 4, 2022
5
SEC EDGARForm 4 filed Nov 1, 2021